Document is current

Any future updates will be listed below

Is the TAE score a promising prognostic predictor for unresectable hepatocellular carcinoma treated with TACE plus lenvatinib with PD‑1 inhibitors? Further validation should be performed

Crossref DOI link: https://doi.org/10.1007/s12072-024-10676-4

Published Online: 2024-05-08

Published Print: 2024-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark